Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial
- 7 September 2020
- conference paper
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64)